Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs.
This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care.
Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policies--as well as the involvement of numerous government agencies--affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures.
The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan.
This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.